KDIGO guidelines include FILSPARI for IgA nephropathy treatment

Go back to KDIGO guidelines include FILSPARI for IgA nephropathy treatment
CARLISLE COMPANIES, Inc. (NYSE: CSL) Delayed: 327.21 -10.32 (3.06%)
Previous Close $337.53    52 Week High $114.49 
Open $334.49    52 Week Low $75.17 
Day High $334.49    P/E 90.64 
Day Low $327.21    EPS $3.61 
Volume 236,727       

(AMEX: CSLLY) Delayed: 30.14 -0.86 (2.77%)
Previous Close $31.00    52 Week High $45.60 
Open $30.22    52 Week Low $33.39 
Day High $30.98    P/E N/A 
Day Low $30.11    EPS $0.00 
Volume 137,595       

(NASDAQ: TVTX) Delayed: 67.13 +0.91 (1.37%)
Previous Close $66.22    52 Week High
Open $65.60    52 Week Low
Day High $68.59    P/E N/A 
Day Low $64.45    EPS
Volume 922,369